LAURA HOSTOVICH: Open Payments
NPI 1588667943 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,510 in 95 payments from 37 companies in 2025. Trend: 2023 $1,517 · 2024 $2,368 · 2025 $2,510
Food & beverage: $2,510
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $330 |
| Janssen Biotech, Inc. | 6 | $260 |
| AstraZeneca Pharmaceuticals LP | 7 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $130 |
| PFIZER INC. | 5 | $110 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
| Daiichi Sankyo Inc. | 3 | $81 |
| ABBVIE INC. | 3 | $79 |
| SOBI, INC | 3 | $68 |
Products named: RYBREVANT, Nubeqa, VPRIV, PLUVICTO, Enhertu, SCEMBLIX, VENCLEXTA, LYNPARZA.
Industry payments across MD — which companies pay providers there.
